Answer
The most common adverse reactions to pegunigalsidase alfa were infusion-related reactions (7.8%), nausea and asthenia (5.6% each), and headache (4.2%).
Sources for this answer
- Elfabrio 2 mg/mL concentrate for solution for infusionChiesi Limited · emc · SmPC §4.8 Undesirable effects · Version 3Document updated
Sources checked